Detailed methodological recommendations for the treatment of Clostridium diffi cile-associated diarrhea with faecal transplantation;Módszertani ajánlás a Clostridium difficile fertozéshez asszociált hasmenés szé klettranszplantációval történo kezelésé hez

Orvosi Hetilap

Volumn 154, Issue 1, 2013, Pages 10-19

  Nagy, Gergely György ^a   Várvölgyi, Csaba ^a   Balogh, Zoltán ^a   Orosi, Piroska ^a   Paragh, György ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Clostridium difficile infection; faecal bacteriotherapy; methodology; protocol; pseudomembranous colitis; stool transplantation

Indexed keywords

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COST EFFECTIVENESS ANALYSIS; FECAL BACTERIOTHERAPY; HEALTH CARE COST; HUMAN; INCIDENCE; MORTALITY; PATIENT SAFETY; PRACTICE GUIDELINE; RECURRENCE RISK; REFRACTORY PERIOD; TRANSPLANTATION;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; GASTROINTESTINAL TRACT; HUMANS; STERILIZATION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84872202732     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2013.29514     Document Type: Article

References (30)

1. Freeman, J., Bauer, M. P., Baines, S. D., et al.: The changing epidemiology of Clostridium diffi cile infections. Clin. Microbiol. Rev., 2010, 23, 529-549.
2. Louie, T. J., Miller, M. A., Mullane, K. M., et al.: Fidaxomicin versus Vancomycin for Clostridium diffi cile infection. N. Engl. J. Med., 2011, 364, 422-431.
3. Cornely, O. A., Miller, M. A., Louie, T. J., et al.: Treatment of fi rst recurrence of Clostridium diffi cile infection: fi daxomicin versus Vancomycin. Clin. Infect. Dis., 2012, 55 (Suppl 2), S154-S161.
4. Vardakas, K. Z., Polyzos, K. A., Patouni, K., et al.: Treatment failure and recurrence of Clostridium diffi cile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int. J. Antimicrob. Agents, 2012, 40, 1-8.
5. Wiegand, P. N., Nathwani, D., Wilcox, M. H., et al.: Clinical and economic burden of Clostridium diffi cile infection in Europe: a systematic review of healthcare-facility-Acquired infection. J. Hosp. Infect., 2012, 81, 1-14.
6. Chang, S., Sievert, D. M., Hageman, J. C., et al.: Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med., 2003, 348, 1342-1347.
7. Weigel, L. M., Clewell, D. B., Gill, S. R., et al.: Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science, 2003, 302, 1569-1571.
8. Méhes, L., Taskó S., Székely, A., et al.: Phagocytosis and intracellular killing of heterogeneous vancomycin-intermediate Staphylococcus aureus strains. J. Med. Microbiol., 2012, 61 (Pt2), 198-203.
9. Butala, P., Divino, C. M.: Surgical aspects of fulminant Clostridium diffi cile colitis. Am. J. Surg., 2010, 200, 131-135.
10. O'Horo, J., Safdar, N.: The role of immunoglobulin for the treatment of Clostridium diffi cile infection: a systematic review. Int. J. Infect. Dis., 2009, 13, 663-667.
11. Foglia, G., Shah, S., Luxemburger, C., et al.: Clostridium diffi cile: Development of a novel candidate vaccine. Vaccine, 2012, 30, 4307-4309.
12. Roberts, A., McGlashan, J., Al-Abdulla, I., et al.: Development and evaluation of an ovine antibody-based platform for treatment of Clostridium diffi cile infection. Infect. Immun., 2012, 80, 875-882.
13. Venugopal, A., Johnson, S.: Current state of Clostridium diffi-cile treatment options. Clin. Infect. Dis., 2012, 55 (Suppl. 2), S71-S76.
14. Gough, E., Shaikh, H., Manges, A. R.: Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium diffi cile infection. Clin. Infect. Dis., 2011, 53, 994-1002.
15. Guo, B., Harstall, C., Louie, T., et al.: Systematic review: faecal transplantation for the treatment of Clostridium diffi cile-Associated disease. Aliment. Pharmacol. Ther., 2012, 35, 865-875.
16. Nagy, G. G., Várvölgyi, Cs., Paragh, Gy.: Successful treatment of life-Threatening, therapy refractory Clostridium diffi cile infection associated pseudomembranous colitis with faecal transplantation. [Életet veszélyezteto, terápiarefrakter Clostri dium diffi-cile fertozés okozta pseudomembranosus colitis sikeres kezelése széklettranszplantációval.] Orv. Hetil., 2012, 153, 2077-2083.
17. Eiseman, B., Silen, W., Bascom, G. S., et al.: Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 1958, 44, 854-859.
18. You, D. M., Franzos, M. A., Holman, R. P.: Successful treatment of fulminant Clostridium diffi cile infection with fecal bacteriotherapy. Ann. Intern. Med., 2008, 148, 632-633.
19. Yoon, S. S., Brandt, L. J.: Treatment of refractroy/recurrent C. diffi cile-Associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J. Clin. Gastroenterol., 2010, 44, 562-566.
20. Russell, G., Kaplan, J., Ferraro, M., et al.: Fecal bacteriotherapy for relapsing Clostridium diffi cile infection in a child: a proposed treatment protocol. Pediatrics, 2010, 126, e239-e242.
21. Aas, J., Gessert, C. E., Bakken, J. S.: Recurrent Clostridium diffi-cile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin. Infect. Dis., 2003, 36, 580-585.
22. Rohlke, F., Surawicz, C. M., Stollman, N.: Fecal fl ora reconstitution for recurrent Clostridium diffi cile infection: results and methodology. J. Clin. Gastroenterol., 2010, 44, 567-570.
23. Kelly, C. R., Leon, L., Jasutkar, N.: Fecal microbiota transplantation for relapsing Clostridium diffi cile infection in 26 patients. Methodology and Results. J. Clin. Gastroenterol., 2012, 46, 145-149.
24. Mattila, E., Uusitalo-Seppälä, R., Wuorela, M., et al.: Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium diffi cile infection. Gastroenterology, 2012, 142, 490-496.
25. Szabó, Zs., Baróthné Tóth, K., Hoffer, I., et al.: Registry and medical check-up of blood donors, and the method of blood donation. Methodological letter. 2nd edition. [Véradók nyilvántartása, véradás elotti kivizsgá lása és a teljes vér vétele. Az OVSZ módszertani levele. 2. kiadás.] OVSZ, Budapest, 2009. [Hungarian]
26. Postigo, R., Kim, J. H.: Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium diffi cile infection: a review and pooled analysis. Infection, 2012, Jul 31.
27. Bakken, J. S.: Fecal bacteriotherapy for recurrent Clostridium diffi cile infection. Anaerobe, 2009, 15, 285-289.
28. Koretz, R. L.: ACP Journal Club: Review: Proton-pump inhibitors are associated with increased risk for Clostridium diffi cile infection. Ann. Intern. Med, 2012, 157, JC 2-JC 13.
29. Garborg, K., Waagsbø, B., Stallemo, A., et al.: Results of faecal donor instillation therapy for recurrent Clostridium diffi cileassociated diarrhoea. Scand. J. Infect. Dis., 2010, 42, 857-861.
30. Aroniadis, O. C., Brandt, L. J.: Fecal microbiota transplantation: past, present and future. Curr. Opin. Gastroenterol., 2012 Oct 4. [Epub ahead of print]